Alkermes ALKS completed its acquisition of Avadel Pharmaceuticals AVDL following the Irish High
Avadel Pharmaceuticals plc Ordinary Share (AVDL) โ Live Session & Technical Brief
Updated Nov 22, 2026 5:09 AM ET ยท Prev Close $21.63
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (+0.05%) in Drug Manufacturers - Specialty & Generic
Avadel Pharmaceuticals plc Ordinary Share (AVDL) is trading within a tight intraday band at $21.64 (+0.05%, 22.59x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AVDL is outperforming the S&P 500 by +3.69%. 14-day RSI stands at 62.3, keeping momentum in a bullish regime.
Alkermes ALKS completed its acquisition of Avadel Pharmaceuticals AVDL following the Irish High
Price ($21.64) holds above both 20-day ($21.56) and 50-day ($21.50) moving averages.
Market & Sector Relative Strength
AVDL outperforming the S&P 500 by +3.69%Recent AVDL Catalyst Headlines
Verified WireFORM 8.3 Irish Takeover Panel Disclosure Under Rule 8.3 Of the Irish Takeover Panel Act, 1997, Takeover Rules, 2013 Dealings by Persons With Interests in Relevant Securities Representing 1 or More 1. Key Information Name
Dublin, February 12, 2026--Alkermes plc Nasdaq ALKS Alkermes and Avadel Pharmaceuticals plc Nasdaq AVDL Avadel today announced Alkermes completion of its acquisition of Avadel, a commercial-stage biopharmaceutical compan
FORM 8.3 Irish Takeover Panel Disclosure Under Rule 8.3 Of the Irish Takeover Panel Act, 1997, Takeover Rules, 2013 Dealings by Persons With Interests in Relevant Securities Representing 1 or More 1. Key Information Name
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $21.56 (20-day SMA support) for directional breakout confirmation.
Technical Regime (AVDL)
BULLISH MA TRENDRetail & Crowd Sentiment
NeutralQube Research & Technologies Limited disclosed interests and short positions in Avadel Pharmaceuticals plc in an Irish Takeover Panel Opening Position Disclosure, representing 1.18% of the company's $0.01 ordinary shares.
About Avadel Pharmaceuticals plc Ordinary Share
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, โฆ
Get Instant AVDL Catalyst Alerts
Receive an email alert when AVDL triggers an unusual volume breakout, options sweep, or rating shift.
AVDL Session & Catalyst FAQ
Why is AVDL stock trading near flat today?
Avadel Pharmaceuticals plc Ordinary Share (AVDL) is trading within a tight intraday band at $21.64 (+0.05%, 22.59x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AVDL is outperforming the S&P 500 by +3.69%. 14-day RSI stands at 62.3, keeping momentum in a bullish regime.
Is AVDL stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 22.59x relative volume (high participation). Our multi-factor model currently rates AVDL as BUY. Review full valuation, quality, and timing signals on the AVDL Buy or Sell Decision Brief โ
What is AVDL's intrinsic value and expected trading range?
At $21.64, AVDL's modeled 1-to-3 session range is $21.16 โ $22.12, with a key inflection level at $21.56 (20-day SMA support). Compare current price against multi-year cash flow projections in the AVDL Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for AVDL?
RSI at 62.3 reflects constructive bullish momentum. AVDL trades at $21.64 relative to its 20-day SMA ($21.56) and 50-day SMA ($21.50), reflecting a bullish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.